Q1 2024 EPS Estimates for Henry Schein, Inc. Lowered by Zacks Research (NASDAQ:HSIC)

Henry Schein, Inc. (NASDAQ:HSIC) – Zacks Research lowered their Q1 2024 earnings per share estimates for Henry Schein in a research report issued on Wednesday, May 1st. Zacks Research analyst U. Biswas now expects that the company will post earnings per share of $0.99 for the quarter, down from their prior estimate of $1.00. The consensus estimate for Henry Schein’s current full-year earnings is $5.07 per share. Zacks Research also issued estimates for Henry Schein’s Q4 2024 earnings at $1.42 EPS, FY2024 earnings at $5.05 EPS, Q1 2026 earnings at $1.46 EPS and FY2026 earnings at $5.99 EPS.

A number of other research analysts have also commented on HSIC. Evercore ISI raised their price target on Henry Schein from $79.00 to $83.00 and gave the company an “in-line” rating in a report on Wednesday, February 28th. Jefferies Financial Group raised their price target on Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a report on Wednesday, March 6th. SVB Leerink assumed coverage on Henry Schein in a report on Monday, February 26th. They set a “market perform” rating and a $78.00 price target on the stock. Piper Sandler raised their price target on Henry Schein from $78.00 to $86.00 and gave the company an “overweight” rating in a report on Monday, February 26th. Finally, TheStreet raised Henry Schein from a “c+” rating to a “b-” rating in a report on Monday, February 26th. One analyst has rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $81.09.

Henry Schein Stock Performance

HSIC stock opened at $67.78 on Friday. The stock has a market capitalization of $8.71 billion, a price-to-earnings ratio of 21.52, a PEG ratio of 1.70 and a beta of 0.87. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.00 and a current ratio of 1.67. Henry Schein has a 1 year low of $60.01 and a 1 year high of $82.63. The stock’s fifty day moving average is $73.46 and its two-hundred day moving average is $72.30.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.70 by ($0.04). The company had revenue of $3.02 billion during the quarter, compared to the consensus estimate of $3 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The business’s quarterly revenue was down 10.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.21 earnings per share.

Hedge Funds Weigh In On Henry Schein

A number of large investors have recently made changes to their positions in the business. McGlone Suttner Wealth Management Inc. acquired a new position in Henry Schein in the fourth quarter worth approximately $39,000. Baystate Wealth Management LLC increased its holdings in Henry Schein by 2,500.0% in the third quarter. Baystate Wealth Management LLC now owns 520 shares of the company’s stock worth $39,000 after buying an additional 500 shares during the last quarter. Neo Ivy Capital Management acquired a new position in Henry Schein in the third quarter worth approximately $46,000. Mather Group LLC. acquired a new position in Henry Schein in the first quarter worth approximately $97,000. Finally, Covestor Ltd increased its holdings in Henry Schein by 22.8% in the third quarter. Covestor Ltd now owns 1,367 shares of the company’s stock worth $102,000 after buying an additional 254 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the company’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the sale, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, Vice Chairman James P. Breslawski sold 2,907 shares of the company’s stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the transaction, the insider now owns 209,562 shares in the company, valued at approximately $15,585,125.94. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Bradford C. Connett sold 6,430 shares of the company’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares in the company, valued at approximately $5,430,462.24. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.